Because decorin has been shown to inhibit the epithelial mesenchymal transition (EMT), this increase in fibroblast-like cells is most likely the result of decorin’s capability to normalize the tumour tissue histology rather than to promote more aggressive mesenchymal phenotype typical for MBC [68–70]. The gene discussed is DCN; the disease is neoplasm.